These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
582 related articles for article (PubMed ID: 25810010)
1. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth. Sen M; Pollock NI; Black J; DeGrave KA; Wheeler S; Freilino ML; Joyce S; Lui VW; Zeng Y; Chiosea SI; Grandis JR Neoplasia; 2015 Mar; 17(3):256-64. PubMed ID: 25810010 [TBL] [Abstract][Full Text] [Related]
2. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma. Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo. Yan S; Li Z; Thiele CJ Oncotarget; 2013 Mar; 4(3):433-45. PubMed ID: 23531921 [TBL] [Abstract][Full Text] [Related]
4. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors. Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas. Lee TL; Yeh J; Van Waes C; Chen Z Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158 [TBL] [Abstract][Full Text] [Related]
6. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma. Kaliyaperumal K; Sharma AK; McDonald DG; Dhindsa JS; Yount C; Singh AK; Won JS; Singh I Redox Biol; 2015 Dec; 6():41-50. PubMed ID: 26177470 [TBL] [Abstract][Full Text] [Related]
7. Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer. Gu L; Liao Z; Hoang DT; Dagvadorj A; Gupta S; Blackmon S; Ellsworth E; Talati P; Leiby B; Zinda M; Lallas CD; Trabulsi EJ; McCue P; Gomella L; Huszar D; Nevalainen MT Clin Cancer Res; 2013 Oct; 19(20):5658-74. PubMed ID: 23942095 [TBL] [Abstract][Full Text] [Related]
8. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma. Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic inhibition of Jak activity inhibits progression of gastrointestinal tumors in mice. Stuart E; Buchert M; Putoczki T; Thiem S; Farid R; Elzer J; Huszar D; Waring PM; Phesse TJ; Ernst M Mol Cancer Ther; 2014 Feb; 13(2):468-74. PubMed ID: 24398427 [TBL] [Abstract][Full Text] [Related]
10. MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma. Mohan S; Vander Broek R; Shah S; Eytan DF; Pierce ML; Carlson SG; Coupar JF; Zhang J; Cheng H; Chen Z; Van Waes C Clin Cancer Res; 2015 Sep; 21(17):3946-56. PubMed ID: 25977343 [TBL] [Abstract][Full Text] [Related]
11. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Chakravarti N; Myers JN; Aggarwal BB Int J Cancer; 2006 Sep; 119(6):1268-75. PubMed ID: 16642480 [TBL] [Abstract][Full Text] [Related]
12. Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding. Sen B; Saigal B; Parikh N; Gallick G; Johnson FM Cancer Res; 2009 Mar; 69(5):1958-65. PubMed ID: 19223541 [TBL] [Abstract][Full Text] [Related]
13. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations. Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer. Liu JF; Deng WW; Chen L; Li YC; Wu L; Ma SR; Zhang WF; Bu LL; Sun ZJ Mol Carcinog; 2018 Mar; 57(3):429-439. PubMed ID: 29215754 [TBL] [Abstract][Full Text] [Related]
15. Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers. Peng S; Creighton CJ; Zhang Y; Sen B; Mazumdar T; Myers JN; Lai SY; Woolfson A; Lorenzi MV; Bell D; Williams MD; Johnson FM J Transl Med; 2013 Aug; 11():198. PubMed ID: 23981300 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of AZD1480 for the treatment of human glioblastoma. McFarland BC; Ma JY; Langford CP; Gillespie GY; Yu H; Zheng Y; Nozell SE; Huszar D; Benveniste EN Mol Cancer Ther; 2011 Dec; 10(12):2384-93. PubMed ID: 22027691 [TBL] [Abstract][Full Text] [Related]
17. Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling. Jia L; Song Q; Zhou C; Li X; Pi L; Ma X; Li H; Lu X; Shen Y PLoS One; 2016; 11(1):e0147157. PubMed ID: 26784960 [TBL] [Abstract][Full Text] [Related]
18. Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins. Tanaka N; Patel AA; Wang J; Frederick MJ; Kalu NN; Zhao M; Fitzgerald AL; Xie TX; Silver NL; Caulin C; Zhou G; Skinner HD; Johnson FM; Myers JN; Osman AA Clin Cancer Res; 2015 Nov; 21(21):4831-44. PubMed ID: 26124202 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells. Baek SH; Ko JH; Lee H; Jung J; Kong M; Lee JW; Lee J; Chinnathambi A; Zayed ME; Alharbi SA; Lee SG; Shim BS; Sethi G; Kim SH; Yang WM; Um JY; Ahn KS Phytomedicine; 2016 May; 23(5):566-77. PubMed ID: 27064016 [TBL] [Abstract][Full Text] [Related]
20. Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma. Dong L; Liu C; Sun H; Wang M; Sun M; Zheng J; Yu X; Shi R; Wang B; Zhou Q; Chen Z; Xing B; Wang Y; Yao X; Mei M; Ren Y; Zhou X Cancer Lett; 2024 Jul; 593():216956. PubMed ID: 38735381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]